联系客服

000028 深市 国药一致


首页 公告 一致B:2022年半年度财务报告(英文版)

一致B:2022年半年度财务报告(英文版)

公告日期:2022-08-31

一致B:2022年半年度财务报告(英文版) PDF查看PDF原文
Section X Financial Reporting
Report of the Auditors

Consolidated financial statements for the six months ended 30 June 2022 haven’t
been audited.


            CHINA NATIONAL ACCORD MEDICINES CORPORATION LTD.

                        CONSOLIDATED BALANCE SHEET

                                As at 30 June 2022

                          (Expressed in Renminbi Yuan)

ASSETS                              Note V                        30 June 2022              31 December 2021
Current assets

  Cash and bank balances                1                        5,573,558,436.74                5,126,159,080.94
  Notes receivable                      2                        634,263,913.50                680,196,380.57
  Accounts receivable                    3                      19,066,131,973.48              15,964,603,345.91
  Receivable financing                    4                        632,101,362.15                1,027,226,940.21
  Advances to suppliers                  5                        384,131,138.51                520,930,545.31
  Other receivables                      6                        624,860,452.74                718,089,129.10
  Inventories                            7                        7,905,185,600.35                7,621,541,595.08
  Contract Assets                        8                          28,169,112.57                  29,061,159.52
  Other current assets                    9                        119,092,606.71                160,607,355.66
Total current assets                                                34,967,494,596.75              31,848,415,532.30
Non-current assets

  Long-term equity investments            10                      2,471,624,418.24                2,459,832,546.74
 Other equity instrument investment        11                          62,488,312.99                  62,488,312.99
  Other  non-current  financial        12

  assets                                                          135,974,908.51                135,974,908.51
  Investment properties                  13                        111,752,949.23                113,981,497.23
  Fixed assets                          14                        835,798,833.09                868,626,258.43
  Construction in progress                15                          34,400,409.22                  49,849,506.70
  Right-of-use assets                    16                      2,628,310,313.99                2,575,240,340.00
  Intangible assets                      17                        681,603,209.30                669,926,562.82
  Goodwill                              18                      2,775,645,585.32                2,775,645,585.32
  Long-term prepaid expenses            19                        603,905,628.79                633,975,441.76
  Deferred tax assets                    20                        184,991,505.33                129,740,169.77
  Other non-current assets                21                        474,990,153.81                  459,985,769.24
Total non-current assets                                            11,001,486,227.82              10,935,266,899.51
Total assets                                                      45,968,980,824.57              42,783,682,431.81
The accompanying notes form an integral part of these financial statements


            CHINA NATIONAL ACCORD MEDICINES CORPORATION LTD.

                  CONSOLIDATED BALANCE SHEET (Continued)

                                As at 30 June 2022

                          (Expressed in Renminbi Yuan)

LIABILITIES AND EQUITY                    Note V                    30 June 2022          31 December 2021
Current liabilities

  Short-term borrowings                        22                  3,099,020,701.18            1,930,467,146.38
  Notes payable                              23                  6,390,557,494.64            7,660,216,823.68
  Accounts payable                            24                  11,329,463,911.07            9,057,718,968.14
  Receipts in advance                          25                    18,140,667.15              19,289,567.44
  Contract liabilities                            26                    446,665,021.01            431,303,231.37
  Employee benefits payable                    27                    240,990,407.92            340,197,125.33
  Tax payable                                28                    361,610,782.83            337,164,080.19
  Other payables                              29                  2,248,815,946.18            1,714,746,986.46
Non-current liabilities due within one year          30                    858,086,989.55            848,328,648.14
  Other current liabilities                        31                    35,657,330.08              39,585,469.65
Total current liabilities                                              25,029,009,251.61          22,379,018,046.78
Non-current liabilities

  Long-term borrowings         
[点击查看PDF原文]